Literature DB >> 27588835

Substrate Specificity of SAMHD1 Triphosphohydrolase Activity Is Controlled by Deoxyribonucleoside Triphosphates and Phosphorylation at Thr592.

Sunbok Jang1, Xiaohong Zhou1, Jinwoo Ahn1.   

Abstract

The sterile alpha motif (SAM) and histidine-aspartate (HD) domain containing protein 1 (SAMHD1) constitute a triphosphohydrolase that converts deoxyribonucleoside triphosphates (dNTPs) into deoxyribonucleosides and triphosphates. SAMHD1 exists in multiple states. The monomer and apo- or GTP-bound dimer are catalytically inactive. Binding of dNTP at allosteric site 2 (AS2), adjacent to GTP-binding allosteric site 1 (AS1), induces formation of the tetramer, the catalytically active form. We have developed an enzyme kinetic assay, tailored to control specific dNTP binding at each site, allowing us to determine the kinetic binding parameters of individual dNTPs at both the AS2 and catalytic sites for all possible combinations of dNTP binding at both sites. Here, we show that the apparent Km values of dNTPs at AS2 vary in the order of dCTP < dGTP < dATP < dTTP. Interestingly, dCTP binding at AS2 significantly reduces the dCTP hydrolysis rate, which is restored to a rate comparable to that of other dNTPs upon dGTP, dATP, or dTTP binding at AS2. Strikingly, a phosphomimetic mutant, Thr592Asp SAMHD1 as well as phospho-Thr592, show a significantly altered substrate specificity, with the rate of dCTP hydrolysis being selectively reduced regardless of which dNTP binds at AS2. Furthermore, cyclin A2 binding at the C-terminus of SAMHD1 induces the disassembly of the SAMHD1 tetramer, suggesting an additional layer of SAMHD1 activity modulation by cyclin A2/CDK2 kinase. Together, our results reveal multiple allosteric mechanisms for controlling the rate of dNTP destruction by SAMHD1.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27588835      PMCID: PMC5225984          DOI: 10.1021/acs.biochem.6b00627

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.

Authors:  S Björklund; S Skog; B Tribukait; L Thelander
Journal:  Biochemistry       Date:  1990-06-12       Impact factor: 3.162

2.  Two genes differentially regulated in the cell cycle and by DNA-damaging agents encode alternative regulatory subunits of ribonucleotide reductase.

Authors:  S J Elledge; R W Davis
Journal:  Genes Dev       Date:  1990-05       Impact factor: 11.361

3.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

4.  SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity.

Authors:  Kyle J Seamon; Zhiqiang Sun; Luda S Shlyakhtenko; Yuri L Lyubchenko; James T Stivers
Journal:  Nucleic Acids Res       Date:  2015-06-22       Impact factor: 16.971

5.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.

Authors:  Elisa Franzolin; Giovanna Pontarin; Chiara Rampazzo; Cristina Miazzi; Paola Ferraro; Elisa Palumbo; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

6.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

7.  The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.

Authors:  K Bebenek; J D Roberts; T A Kunkel
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

Review 8.  Intracellular nucleotide levels and the control of retroviral infections.

Authors:  Sarah M Amie; Erin Noble; Baek Kim
Journal:  Virology       Date:  2012-12-20       Impact factor: 3.616

9.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

10.  Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.

Authors:  Junpeng Yan; Sarabpreet Kaur; Maria DeLucia; Caili Hao; Jennifer Mehrens; Chuanping Wang; Marcin Golczak; Krzysztof Palczewski; Angela M Gronenborn; Jinwoo Ahn; Jacek Skowronski
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

View more
  10 in total

1.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

2.  Phosphorylation of SAMHD1 Thr592 increases C-terminal domain dynamics, tetramer dissociation and ssDNA binding kinetics.

Authors:  Benjamin Orris; Kevin W Huynh; Mark Ammirati; Seungil Han; Ben Bolaños; Jason Carmody; Matthew D Petroski; Benedikt Bosbach; David J Shields; James T Stivers
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

Review 3.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

4.  Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis.

Authors:  Sarah J Caswell; Simone Kunzelmann; Elizabeth R Morris; Laurence H Arnold; Andrew G Purkiss; Geoff Kelly; Ian A Taylor
Journal:  Nat Commun       Date:  2020-06-23       Impact factor: 14.919

5.  The crystal structure of dGTPase reveals the molecular basis of dGTP selectivity.

Authors:  Christopher O Barnes; Ying Wu; Jinhu Song; Guowu Lin; Elizabeth L Baxter; Aaron S Brewster; V Nagarajan; Andrew Holmes; S Michael Soltis; Nicholas K Sauter; Jinwoo Ahn; Aina E Cohen; Guillermo Calero
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-24       Impact factor: 11.205

6.  Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication.

Authors:  Kun Zhang; Dong-Wen Lv; Renfeng Li
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

7.  SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.

Authors:  Matthew A Szaniawski; Adam M Spivak; James E Cox; Jonathan L Catrow; Timothy Hanley; Elizabeth S C P Williams; Michel J Tremblay; Alberto Bosque; Vicente Planelles
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

8.  DCTPP1 prevents a mutator phenotype through the modulation of dCTP, dTTP and dUTP pools.

Authors:  Blanca Martínez-Arribas; Cristina E Requena; Guiomar Pérez-Moreno; Luis M Ruíz-Pérez; Antonio E Vidal; Dolores González-Pacanowska
Journal:  Cell Mol Life Sci       Date:  2019-08-03       Impact factor: 9.261

Review 9.  SAMHD1 Functions and Human Diseases.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

10.  Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Authors:  Sean G Rudd; Nikolaos Tsesmetzis; Kumar Sanjiv; Cynthia Bj Paulin; Lakshmi Sandhow; Juliane Kutzner; Ida Hed Myrberg; Sarah S Bunten; Hanna Axelsson; Si Min Zhang; Azita Rasti; Petri Mäkelä; Si'Ana A Coggins; Sijia Tao; Sharda Suman; Rui M Branca; Georgios Mermelekas; Elisée Wiita; Sun Lee; Julian Walfridsson; Raymond F Schinazi; Baek Kim; Janne Lehtiö; Georgios Z Rassidakis; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Mats Heyman; Dan Grandér; Sören Lehmann; Thomas Lundbäck; Hong Qian; Jan-Inge Henter; Torsten Schaller; Thomas Helleday; Nikolas Herold
Journal:  EMBO Mol Med       Date:  2020-01-17       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.